ouabain has been researched along with ketorolac in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Crecelius, AR; Dinenno, FA; Kirby, BS; Larson, DG; Luckasen, GJ | 1 |
| Crecelius, AR; Dinenno, FA; Larson, DG; Luckasen, GJ | 1 |
| Crecelius, AR; Dinenno, FA; Hearon, CM; Kirby, BS; Larson, DG; Luckasen, GJ | 1 |
2 trial(s) available for ouabain and ketorolac
| Article | Year |
|---|---|
ATP-mediated vasodilatation occurs via activation of inwardly rectifying potassium channels in humans.
Topics: Acetylcholine; Adenosine Triphosphate; Adult; Barium Compounds; Chlorides; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Female; Humans; Ketorolac; Male; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Ouabain; Potassium Channels, Inwardly Rectifying; Potassium Chloride; Sodium-Potassium-Exchanging ATPase; Vasodilation; Vasodilator Agents; Young Adult | 2012 |
Contracting human skeletal muscle maintains the ability to blunt α1 -adrenergic vasoconstriction during KIR channel and Na(+) /K(+) -ATPase inhibition.
Topics: Adenosine; Adult; Barium Compounds; Brachial Artery; Chlorides; Exercise; Female; Forearm; Hand Strength; Humans; Ketorolac; Male; Muscle Contraction; Muscle, Skeletal; omega-N-Methylarginine; Ouabain; Potassium Channels, Inwardly Rectifying; Propranolol; Receptors, Adrenergic, alpha-1; Regional Blood Flow; Sodium-Potassium-Exchanging ATPase; Vasoconstriction; Young Adult | 2015 |
5 other study(ies) available for ouabain and ketorolac
| Article | Year |
|---|---|
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
KIR channel activation contributes to onset and steady-state exercise hyperemia in humans.
Topics: Adult; Barium Compounds; Chlorides; Cyclooxygenase Inhibitors; Exercise; Female; Forearm; Humans; Hyperemia; Ketorolac; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Ouabain; Potassium Channel Blockers; Potassium Channels, Inwardly Rectifying; Prostaglandins; Regional Blood Flow; Sodium-Potassium-Exchanging ATPase; Vasoconstriction | 2014 |